Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.9469
+0.0119 (1.27%)
Nov 28, 2025, 1:00 PM EST - Market closed
Dyadic International Revenue
Dyadic International had revenue of $1.16M in the quarter ending September 30, 2025, a decrease of -40.50%. This brings the company's revenue in the last twelve months to $3.34M, down -0.66% year-over-year. In the year 2024, Dyadic International had annual revenue of $3.50M with 20.58% growth.
Revenue (ttm)
$3.34M
Revenue Growth
-0.66%
P/S Ratio
9.37
Revenue / Employee
$557,033
Employees
6
Market Cap
34.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.50M | 596.58K | 20.58% |
| Dec 31, 2023 | 2.90M | -31.50K | -1.07% |
| Dec 31, 2022 | 2.93M | 526.47K | 21.90% |
| Dec 31, 2021 | 2.40M | 801.91K | 50.06% |
| Dec 31, 2020 | 1.60M | -79.16K | -4.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
DYAI News
- 17 days ago - Dyadic International, Inc. (DYAI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress - GlobeNewsWire
- 4 weeks ago - Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025 - GlobeNewsWire
- 7 weeks ago - Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments - GlobeNewsWire
- 3 months ago - Dyadic to Present at Investor Conferences and BPI East - GlobeNewsWire
- 3 months ago - Dyadic International, Inc. (DYAI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress - GlobeNewsWire
- 4 months ago - Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025 - GlobeNewsWire